Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 1
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Ligand-dependent downregulation of MR1 cell surface expression.
Salio M, Awad W, Veerapen N, Gonzalez-Lopez C, Kulicke C, Waithe D, Martens AWJ, Lewinsohn DM, Hobrath JV, Cox LR, Rossjohn J, Besra GS, Cerundolo V. Salio M, et al. Among authors: martens awj. Proc Natl Acad Sci U S A. 2020 May 12;117(19):10465-10475. doi: 10.1073/pnas.2003136117. Epub 2020 Apr 27. Proc Natl Acad Sci U S A. 2020. PMID: 32341160 Free PMC article.
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy.
van Bruggen JAC, Martens AWJ, Fraietta JA, Hofland T, Tonino SH, Eldering E, Levin MD, Siska PJ, Endstra S, Rathmell JC, June CH, Porter DL, Melenhorst JJ, Kater AP, van der Windt GJW. van Bruggen JAC, et al. Among authors: martens awj. Blood. 2019 Jul 4;134(1):44-58. doi: 10.1182/blood.2018885863. Epub 2019 May 10. Blood. 2019. PMID: 31076448 Free PMC article.
Innate Lymphoid Cells in Tumor Immunity.
van Beek JJP, Martens AWJ, Bakdash G, de Vries IJM. van Beek JJP, et al. Among authors: martens awj. Biomedicines. 2016 Feb 25;4(1):7. doi: 10.3390/biomedicines4010007. Biomedicines. 2016. PMID: 28536374 Free PMC article. Review.
Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma.
van Bruggen JAC, Martens AWJ, Tonino SH, Kater AP. van Bruggen JAC, et al. Among authors: martens awj. Cancers (Basel). 2020 Dec 18;12(12):3837. doi: 10.3390/cancers12123837. Cancers (Basel). 2020. PMID: 33353234 Free PMC article. Review.
Human CXCR5+ PD-1+ CD8 T cells in healthy individuals and patients with hematologic malignancies.
Hofland T, Martens AWJ, van Bruggen JAC, de Boer R, Schetters S, Remmerswaal EBM, Bemelman FJ, Levin MD, Bins AD, Eldering E, Kater AP, Tonino SH. Hofland T, et al. Among authors: martens awj. Eur J Immunol. 2020 Oct 24. doi: 10.1002/eji.202048761. Online ahead of print. Eur J Immunol. 2020. PMID: 33098668
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.
Martens AWJ, Janssen SR, Derks IAM, Adams Iii HC, Izhak L, van Kampen R, Tonino SH, Eldering E, van der Windt GJW, Kater AP. Martens AWJ, et al. J Immunother Cancer. 2020 Jun;8(1):e000218. doi: 10.1136/jitc-2019-000218. J Immunother Cancer. 2020. PMID: 32581054 Free PMC article.